Cholesterol Disorders

 

The Practical Cardiology™ Cholesterol Disorders clinical resource center offers the latest information from the field of lipidology. With hypercholesterolemia and hyperlipidemia representing a crucial aspect of risk management, this page will be a hub for information related to the latest in cholesterol management and dyslipidemia, including articles, videos, and podcasts.

Matthew Budoff, MD: Need for Greater Uptake of Newer Medications

September 15, 2021

Matthew Budoff, MD, discusses what he views as hurdles to achieving optimal prescription of newer agents in the treatment of cardiometabolic conditions, including diabetes, heart failure, dyslipidemia, and more.

Cardiology Month in Review: July 2021

July 31, 2021

July's month in review features stories related to EMPEROR-Preserved meeting primary endpoint, a Q&A with Javed Butler, MD, on heart failure prevention, comparing ACEs vs ARBs, and more. Check back around the end of each month for the next Cardiology Month in Review.

ACC.21 Simulation Study Estimates CV Event Risk Reduction with Bempedoic Acid

May 19, 2021

A pooled risk simulation of phase 3 data of bempedoic acid suggests the first-in-class ATP citrate lyase inhibitor could reduce risk of cardiovascular events in patients with established cardiovascular disease and elevated LDL-C.

How STRENGTH Results Impact REDUCE-IT, with Deepak Bhatt, MD, MPH

May 16, 2021

As part of our coverage of ACC.21, Practical Cardiology reached out to Deepak Bhatt, MD, MPH, to learn about his reaction to the latest analysis of the STRENGTH trial and how it might impact how REDUCE-IT results are interpreted.